X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Sensex ends the week 2.9% lower 
(Fri, 24 May Closing) 
 
Select heavyweights from the commodity, auto and power sectors helped the key indices in Indian equity markets remain in the positive today along with the ones Japan, China and Indonesia. Rest of the major Asian indices closed lower today. While the BSE-Sensex closed higher by 30 points, the NSE-Nifty closed higher by 17 points. The BSE Mid Cap index and the BSE Small Cap index gained 0.3% each.

As regards global markets, Asian indices closed mixed today while European indices have opened lower. The rupee was trading at Rs 55.60 to the dollar at the time of writing.

Pharma major Wockhardt was at the receiving end of investor apathy today as the stock corrected by nearly 7% during the session. This is in reponse to the 'import alert' that the company has received from the USFDA on one of its manufacturing unit located in Waluj near Aurangabad. The impact of the import alert on the revenues is estimated to be in the range of US$ 100 m on an annualised basis. It is also important to note that the said facility is the only injectable plant where the company holds USFDA approval. As on date, the company holds approval of approximately 30-35 injectables. The company's management has clarified that it is taking all steps to address the concerns raised by USFDA and shall put all efforts to resolve the issue at the earliest.

As per a business daily, infrastructure conglomerate Larsen & Toubro (L&T) is likely to increase its focus on international expansion and aims to get more than double its overseas orders to Rs 250 bn this fiscal (FY14). In financial year 2013 (FY13), the company had bagged orders worth Rs 880 bn, out of which international order inflow constituted a good 17% (Rs 120 bn), twice as that in previous year. The company is expecting nearly Rs 250 bn worth orders from Far East and West Asia market in current fiscal. Further, L&T also sees good prospects in countries like Middle East, select markets in CIS region, Africa and South Asia.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Sensex ends the week 2.9% lower". Click here!

  
 

S&P BSE HEALTHCARE


Apr 24, 2017 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS